Physician profile
David Fu
NPI 1447991823
$1,229.58
in general payments reported to CMS, 2019-2025
9 companies · $867 in 2025
The $867 reported for 2025 was more than what 86% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $363 · 2025: $867.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,136 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,135.58 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calyxo, INC. | $280.37 | 2025 | Cvac Aspiration System |
| Boston Scientific Corporation | $215.59 | 2024-2025 | Accolade Sr, General - Erectile Dysfunction |
| Photocure INC | $185.35 | 2025 | Cysview |
| Janssen Scientific Affairs, LLC | $141.29 | 2025 | Erleada |
| Ferring Pharmaceuticals INC. | $121.31 | 2024 | |
| Angiodynamics, INC. | $120.62 | 2024 | Nanoknife |
| Astellas Pharma US INC | $94.00 | 2024 | |
| Janssen Biotech, INC. | $48.14 | 2025 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $22.91 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Fu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.